Scheme for synthesis of glutathione derivatives for kinetic assays
Scheme S1. Synthesis of glutathione derivatives for kinetic assays with GSTP, GSTO, and GR. Table S1 Figure S1
. Kinetic analysis of glutathione-and azido-glutathione-containing substrates with GSTP1, Grx1, GR, and GSTO1. To calculate kcat and Km values, initial reaction rates were plotted with a range of substrate concentrations by using Graphpad Prism.
Figure S4. Redox changes and viability of cells under glucose starvation with treatment of antimycin A. (A) ROS induction assays:
HEK293 cells were subjected to indicated conditions for 2-h, and cells were tested for ROS increases by 2',7'-dichlorodihydrofluorescein diacetate (DCF-DA) assay: none (25 mM glucose), (-) GL (0 mM glucose), (+) AMA (2 μg/mL antimycin A), and (-) GL (+) AMA (0 mM glucose, 2 μg/mL antimycin A). (B) Viability assays: HEK293 cells were subjected to indicated conditions for 24-h: none (25 mM glucose), (-) GL (0 mM glucose), (+) AMA (1 μg/mL antimycin A), and (-) GL (+) AMA (0 mM glucose, 1 μg/mL antimycin A). Cells were then tested for viability by Trypan blue assay. (C) Levels of redox enzymes: after HEK293 cells were subjected to indicated conditions for 2 h, individual antibodies were used for Western blotting. (D) The level of cellular thiols: after HEK293 cells were subjected to indicated conditions for 2-h, thiol concentrations in cell lysates free from proteins was measured by bromobimane assay in the presence and absence of TCEP, which were used to determine the total, the reduced form, and oxidized form of thiols (glutathione), respectively, in cell lysates. 
Experimental procedure

Material
All chemicals were purchased from Sigma unless otherwise stated. 3-Azido-L-alanine HCl (Azido-Ala) was purchased from Jena Biosciences (Germany). EDTA-free protease inhibitor cocktail tablets were purchased from Roche. All cell culture reagents and medium were purchased from Life Technologies. Streptavidin-horseradish peroxidase (HRP) and high capacity streptavidin agarose beads were purchased from Thermo Scientific. HRP-conjugated anti-mouse and antirabbit secondary antibodies were purchased from GE healthcare. Light chain specific HRPconjugated mouse and rabbit secondary antibodies were purchased from Jackson ImmunoResearch and ECM Biosciences, respectively. Polyethyleneimine-MAX was purchased from Polysciences, Inc (USA). Reduced glutathione (Sigma), oxidized glutathione (Acros), 2,2-dithiodipyridine (Acros), γ-glutamyl-cysteine (Sigma), 1-chloro-2,4-dinitrobenzene (CDNB) (Sigma), human glutathione reductase (Sigma), and 2,7-dichlorodihydrofluorescein diacetate (DCF-DA) (Sigma)
were purchased. Glutaredoxin 1 (Grx1) was purified as reported previously. 
Synthesis of glutathione derivatives
Synthesis of azido-glutathione (2)
Clickable glutathione containing L-azido-Ala (azido-glutathione, N3 GSH) was synthesized using GS M4 enzyme, which catalyze L-azido-Ala in place of Gly. 3.5 mM azido-alanine (azido-Ala, 5.9 mg), 3.0 mM γ-glutamyl-cysteine, 10 mM ATP, 50 mM MgCl2, 300 mM NaCl, 200 mM Tris buffer (pH 7.4) and GS M4 (80 ng) were mixed in 10 ml final reaction mixture and incubated overnight at 37 o C. After acidification (pH 2-3) by adding 1 M HCl, the mixture was centrifuged at 10,000 rpm for 5 min. The supernatant aqueous solution was subjected to reversephase C18 column HPLC purification (gradient mobile phase: H2O and CH3CN), and the disulfide of azido-glutathione was obtained as a white solid after lyophilization. The purity and mass were confirmed by ESI-MS and LC-MS. Disulfide of azido-glutathione was reduced using dithiothreitol (DTT) (2 equivalent) in 100 mM PBS (pH 7.4) at room temperature for 1 h. The mixture was acidified by addition of 1 M HCl (pH 2-3), and centrifuged at 10,000 rpm for 4 min. The supernatant acidic aqueous layer was subjected to reverse-phase C18 column HPLC purification, and the reduced azido-glutathione was obtained as a white solid after lyophilization, giving azido-glutathione (2) (8 mg, 56%). The purity and mass were confirmed by ESI-MS and LC-MS. Calculated mass: 362.10 Found mass: ESI m/z 363.07 (M+H) 725.18 (2M+H).
Synthesis of GS-S-Pyr (3) and N3 GS-SPyr (4)
Glutathione ( 
Synthesis of N3 GSSG (6)
S-(2-thiopyridyl)azido-glutathione ( N3 GS-S-Pyr, 4, 7.0 mg, 1 equivalent) and glutathione (GSH, 
Synthesis of GSS-Pep (8mer) (7) and N3 GSS-Pep (8mer) (8) S-(2-thiopyridyl)glutathione (GS-S-
Purification of GSTO and GSTP
Human GSTP1 cDNA clone (OriGene) and Human GSTO1 cDNA clone (gift from Dr. YoungTae Chang, National University of Singapore) were subcloned in to pET-28a(+) bacterial expression vector using NheI/XhoI (GSTP1) and NdeI/XhoI (GSTO1) restriction sites. PCR reaction was performed using forward primer ( 
Spectrophotometric assay of GR activity
Kinetic parameters for glutathione disulfide reductase (GR) were determined by measuring The plot of the initial velocity versus substrate concentrations was fitted to the Michaelis-Menten equation using Graphpad prism 5.01 and kinetic constants (K m , k cat and V max ) for GSSG and N3 GSSG were calculated accordingly.
Spectrophotometric assay of Grx1 and GSTO1 activity
The coupled spectrophotometric assay involving above two reactions was used as reported previously. 3 Excess GR was used so that the second step is not a limiting step. Note that GR catalyzes N3 GSH with the similar kcat and lower Km than GSH ( Table 1 
ROS assays
HEK293 cells (10,000 cells per well) were seeded and incubated at 37 o C, 5% CO2 for 24 h for attachment on 96-well black plates with transparent flat bottom. Cells were then washed with warm PBS, and incubated in serum-free medium for 3 h. 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA, 25 µM) was then added, and cells were incubated in the same conditions for another 1 h. Cells were then washed with glucose-free medium without phenol red, followed by treatment at the indicated conditions and incubated for 2 h. Untreated cells acted as a negative control.
Fluorescence emission scan was measured at 528 nm after excitation at 485 nm. ROS levels were normalized by a negative control (25 mM glucose without antimycin A). analyzed by fluorescence assay using bromobimane (excitation -390 nm, emission-478 nm). 6 Bromobimane assay was performed in 0.1 M phosphate buffer, 0.5 mM bromobimane, and 10 µL of protein free lysates (FIL). The fluorescence signal was measured by using a plate reader. To calculate total GSH levels, protein free lysates (FIL) were incubated with 1 mM TCEP at 37 o C for 30 minutes before the bromobimane assay. All the data was duplicated and the background signal was corrected.
3.6 Cloning, expression, and enzyme assays of PP2Cα
Cloning and mutagenesis
Human PP2Cα cDNA clone was purchased from OriGene and the gene was subcloned into pcDNA3.1/hygro (+) mammalian vector using BamHI and XhoI restriction sites. PCR reaction was performed using forward primer (5'-GGT GGT GGA TCC GCC ACC ATG GGA GCA TTT TTA GAC AAG C-3') containing Kozak sequence and BamHI restriction site and (5'-GGT GGT CTC GAG CTA AGC GTA ATC TGG AAC ATC GTA TGG GTA CCA CAT ATC ATC TGT TGA TGT AGA G-3') as the reverse primer containing HA tag and XhoI restriction site. Both PCR product and the empty pcDNA3.1 vector were double digested with above two restriction enzymes and ligated using T4 DNA ligase. All the mutants were generated using pcDNA3.1-PP2Cα clone as the template. Quick change mutagenesis was performed using following 
Purification of PP2Cα
pET28a-PP2Cα was transformed in to BL21(DE3) cells and single colony was inoculated overnight in LB containing 50 µg/mL kanamycin. 5 mL overnight culture was diluted in to 1 L LB and grew at 37 o C until OD600 reaches 0.4. Protein overexpression was induced for 4 h at 37 o C with 0.5 mM IPTG. Cells were harvested, lysed and purified as described in section 3.3.
Enzyme assays of PP2Cα
PP2Cα enzyme (WT and C314S) activities were calculated by end point assay using para- (µmoles/min/µg) were calculated using absorbance measured at 405 nm.
